193 related articles for article (PubMed ID: 18203016)
1. Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome: comparison of T-cell lymphoma with and without hemophagocytic syndrome.
Tong H; Ren Y; Liu H; Xiao F; Mai W; Meng H; Qian W; Huang J; Mao L; Tong Y; Wang L; Qian J; Jin J
Leuk Lymphoma; 2008 Jan; 49(1):81-7. PubMed ID: 18203016
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological study on peripheral T-cell non-Hodgkin lymphoma with bone marrow involvement: a retrospective analysis from China.
Tong H; Ren Y; Qian W; Xiao F; Mai W; Meng H; Jin J
Int J Hematol; 2009 Oct; 90(3):303-310. PubMed ID: 19728028
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and treatment of natural killer/T cell lymphoma associated with hemophagocytic syndrome: comparison with other T cell lymphoma associated with hemophagocytic syndrome.
Han L; Li L; Wu J; Li X; Zhang L; Wang X; Fu X; Ma W; Sun Z; Zhang X; Chang Y; Guo S; Zhang M
Leuk Lymphoma; 2014 Sep; 55(9):2048-55. PubMed ID: 24359240
[TBL] [Abstract][Full Text] [Related]
4. Multivariate analysis of prognosis for patients with natural killer/T cell lymphoma-associated hemophagocytic lymphohistiocytosis.
Jin Z; Wang Y; Wang J; Wu L; Pei R; Lai W; Wang Z
Hematology; 2018 May; 23(4):228-234. PubMed ID: 28982299
[TBL] [Abstract][Full Text] [Related]
5. An effective diagnostic index for lymphoma-associated hemophagocytic syndrome.
Xie M; Li L; Zhu L; Zhou D; Yang X; Sun J; Zhu J; Zhu M; Zheng Y; Xie W; Ye X
QJM; 2018 Aug; 111(8):541-547. PubMed ID: 29800321
[TBL] [Abstract][Full Text] [Related]
6. A clinical study of 21 patients with hemophagocytic syndrome in 295 cases diagnosed with nasal type, extranodal nature killer/T cell lymphoma.
Li N; Zhang L; Liu J; Zhang J; Weng HW; Zhuo HY; Zou LQ
Cancer Biol Ther; 2017 Apr; 18(4):252-256. PubMed ID: 28278074
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and survival of extranodal natural killer/T cell lymphoma with and without hemophagocytic syndrome.
Jia J; Song Y; Lin N; Liu W; Ping L; Zheng W; Wang X; Xie Y; Tu M; Zhang C; Ying Z; Deng L; Ding N; Zhu J
Ann Hematol; 2016 Dec; 95(12):2023-2031. PubMed ID: 27595760
[TBL] [Abstract][Full Text] [Related]
8. Clinical analysis and prognostic significance of lymphoma-associated hemophagocytosis in peripheral T cell lymphoma.
Xie W; Hu K; Xu F; Zhou D; He J; Shi J; Luo Y; Zhu J; Zhang J; Lin M; Ye X; Huang H; Cai Z
Ann Hematol; 2013 Apr; 92(4):481-6. PubMed ID: 23238896
[TBL] [Abstract][Full Text] [Related]
9. Identification of clinical features of lymphoma-associated hemophagocytic syndrome (LAHS): an analysis of 69 patients with hemophagocytic syndrome from a single-center in central region of China.
Li F; Li P; Zhang R; Yang G; Ji D; Huang X; Xu Q; Wei Y; Rao J; Huang R; Chen G
Med Oncol; 2014 Apr; 31(4):902. PubMed ID: 24610542
[TBL] [Abstract][Full Text] [Related]
10. Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome.
Han AR; Lee HR; Park BB; Hwang IG; Park S; Lee SC; Kim K; Lim HY; Ko YH; Kim SH; Kim WS
Ann Hematol; 2007 Jul; 86(7):493-8. PubMed ID: 17347847
[TBL] [Abstract][Full Text] [Related]
11. [Clinical characteristics and prognosis of lymphoma-associated hemophagocytic syndrome].
Zhao AL; Li M; Li LF; Gan XA; Wang J; Li H; Shen K; Yang YF; Niu T
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(28):2173-2180. PubMed ID: 35872581
[No Abstract] [Full Text] [Related]
12. Lymphoma-associated hemophagocytic syndrome: a retrospective study from a single center.
Li N; Jiang M; Wu WC; Zhou HJ; Zou LQ
Hematology; 2022 Dec; 27(1):909-916. PubMed ID: 35993333
[TBL] [Abstract][Full Text] [Related]
13. High concentration of miR-133 is a useful marker for the diagnosis of lymphoma- associated hemophagocytic syndrome.
Li W; Zhong Y; Shuang Y; Huang H; Huang Y; Yu L; Huang X
Cancer Biomark; 2017 Aug; 20(2):159-164. PubMed ID: 28869447
[TBL] [Abstract][Full Text] [Related]
14. Autologous Hematopoietic Stem Cell Transplantation for Patients with Lymphoma-Associated Hemophagocytic lymphohistiocytosis.
Song Y; Yin Q; Wang J; Wang Z
Cell Transplant; 2021; 30():9636897211057077. PubMed ID: 34743574
[TBL] [Abstract][Full Text] [Related]
15. [Lymphoma-associated hemophagocytic syndrome in Japan].
Takahashi N; Chubachi A; Miura I; Nakamura S; Miura AB
Rinsho Ketsueki; 1999 Jul; 40(7):542-9. PubMed ID: 10483136
[TBL] [Abstract][Full Text] [Related]
16. The emerging role of anti-PD-1 antibody-based regimens in the treatment of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
He Y; Gao Y; Ping L; He H; Huang C; Bai B; Wang X; Li Z; Cai Q; Huang Y; Pan X; Zeng W; Liu Y; Huang H
J Cancer Res Clin Oncol; 2023 May; 149(5):2017-2027. PubMed ID: 35809114
[TBL] [Abstract][Full Text] [Related]
17. [Clinical Analysis of 10 Cases of B Cell Lymphoma-Associated Hemophagocytic Syndrome].
Zhong FL; Zhang HY; Zhang Q; Zhang WL; Feng J; Meng QX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug; 25(4):1022-1029. PubMed ID: 28823262
[TBL] [Abstract][Full Text] [Related]
18. A high sIL-2R/ferritin ratio is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome.
Tsuji T; Hirano T; Yamasaki H; Tsuji M; Tsuda H
Ann Hematol; 2014 May; 93(5):821-6. PubMed ID: 24705932
[TBL] [Abstract][Full Text] [Related]
19. Lymphoma-associated hemophagocytic syndrome (LAHS) in advanced-stage mycosis fungoides/Sézary syndrome cutaneous T-cell lymphoma.
Blom A; Beylot-Barry M; D'Incan M; Laroche L
J Am Acad Dermatol; 2011 Aug; 65(2):404-410. PubMed ID: 21550694
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Significance of Beta2 Microglobulin in Patients with Hemophagocytic Lymphohistiocytosis.
Jiang T; Ding X; Lu W
Dis Markers; 2016; 2016():1523959. PubMed ID: 27110054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]